| Author (Corporate) | European Commission: DG Competition |
|---|---|
| Publication Date | 30/04/2018 |
| Content Type | News |
|
Further information: The European Commission conditionally approved on 30 April 2018 under the EU Merger Regulation the acquisition of parts of Bayer's Crop Science business by BASF. The decision followed the Commission's conditional clearance of Bayer's planned acquisition of Monsanto, announced in March 2018. Bayer committed to divest an extensive remedy package worth well over €6 billion (the 'Bayer Divestment Business') to address the competition concerns on overlaps between Bayer and Monsanto in seeds, pesticides and digital agriculture. The Commission concluded that this divestment package would enable a suitable buyer to sustainably replace Bayer's competitive effect in these markets and continue to innovate, for the benefit of European farmers and consumers. BASF notified this transaction to the Commission for assessment under the EU Merger Regulation on 7 March 2018. On 9 April 2018, BASF adapted the scope of the initially notified transaction in order to reflect changes to the Bayer Divestment Business. This followed Bayer's requests to modify the commitments in the Bayer/Monsanto transaction as regards nematicidal seed treatments and digital agriculture, which the Commission approved on 11 April 2018 |
|
| Source Link | http://ec.europa.eu/competition/elojade/isef/case_details.cfm?proc_code=2_M_8851 |
| Related Links |
|
| Subject Categories | Business and Industry, Internal Markets |
| Countries / Regions | Europe |
